Skip to main content
Epitomee Medical Ltd (TLV:EPIT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
806.50
-0.90 (-0.11%)
Mar 6, 2026, 1:44 PM IDT

Epitomee Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
--10---
Gross Profit
--10---
Selling, General & Admin
2.993.442.793.282.60.74
Research & Development
5.755.546.87.796.183.1
Other Operating Expenses
-6.97-6.977.18---
Operating Expenses
1.76216.7611.078.773.85
Operating Income
-1.76-2-6.76-11.07-8.77-3.85
Interest Expense
--0.19-0.06--2.71-0.07
Interest & Investment Income
2.061.21.60.480.070.09
Currency Exchange Gain (Loss)
-0.46-0.46-0.46-4.9-0.10.01
Other Non Operating Income (Expenses)
-0.01-0.01-0.010.1-0.65
Pretax Income
0.33-1.46-5.68-15.39-11.52-3.17
Net Income
0.33-1.46-5.68-15.39-11.52-3.17
Net Income to Common
0.33-1.46-5.68-15.39-11.52-3.17
Shares Outstanding (Basic)
3030302920
Shares Outstanding (Diluted)
3030302920
Shares Change (YoY)
0.19%0.36%0.69%1575.26%669.53%-
EPS (Basic)
0.01-0.05-0.19-0.52-6.55-13.86
EPS (Diluted)
0.01-0.05-0.19-0.52-6.55-13.86
Free Cash Flow
-12.64-12.91-12-13.12-6.166.64
Free Cash Flow Per Share
-0.42-0.43-0.40-0.45-3.5029.08
Gross Margin
--100.00%---
Operating Margin
---67.63%---
Profit Margin
---56.82%---
Free Cash Flow Margin
---119.96%---
EBITDA
-1.09-1.58-6.55-11.01-8.72-3.8
EBITDA Margin
---65.49%---
D&A For EBITDA
0.670.420.210.060.050.05
EBIT
-1.76-2-6.76-11.07-8.77-3.85
EBIT Margin
---67.63%---
Source: S&P Capital IQ. Standard template. Financial Sources.